On Tuesday, October 26, the Subcommittee on Health of the Committee on Energy and Congress held a hearing titled, “Caring for America: Legislation to Support Patients, Caregivers, and Providers.”
Seven bills were “heard” as part of this hearing including the Allied Health Workforce Diversity Act (H.R. 3320). The Academy strongly supports this legislation and has worked collaboratively with other allied health-related associations representing the additional provider types to lobby for and secure congressional support for this legislation.
This legislation provides $5 million per year in grants and stipends for students of racial or ethnic minorities, disadvantaged backgrounds, or with disabilities, in programs preparing audiologists, occupational therapists, physical therapists, speech-language pathologists, and respiratory therapists. ACAE-accredited audiology programs are specifically recognized, and the Academy is listed as an organization that would provide input into the disbursement of funds.
This legislation is critical in light of the fact that the population of people treated by audiologists, occupational therapists, physical therapists, speech-language pathologists (SLPs), and respiratory therapists is far more diverse than the professionals treating them.
In addition, a recent Institutes of Medicine report found that patients who receive treatment from professionals of similar ethnic background often trust their therapists more and are more likely to follow through on their treatment.
Recent Posts
Audiology CPT® Codes Enter Routine AMA RUC Review Process
Over the next several months, a significant number of CPT® codes used to report audiology function tests will undergo review through the AMA/Specialty Society Relative…
Academy Advocacy on Capitol Hill for Student Loan Reform and EHDI Support
Last week, Joanne Zurcher, MPP, and Academy member Melissa Heche, AuD, traveled to Capitol Hill to advocate for two important Academy priorities: protecting access to…
A New Era in Hearing Care: FDA Approves OTOF Gene Therapy
In the United States, mutations in the OTOF-gene (otoferlin gene) account for between one percent and eight percent of non-syndromic congenital hearing loss (Ford et…


